Table 3.
Mean Survival of Patients with CRC, By ACE Genotype.
| Gender | n (%) | I/D Genotype | Survival (Months) [Mean ± SD] | P |
| Whole study population | 29 (28) | II | 38.04 ± 4.75 | .508 |
| 48 (46) | ID | 45.29 ± 3.94 | ||
| 27 (26) | DD | 46.37 ± 4.90 | ||
| 75 (72) | ID + DD | 46.13 ± 3.13 | .250* | |
| Men | 22 (34) | II | 40.06 ± 5.54 | .704 |
| 22 (34) | ID | 47.95 ± 5.63 | ||
| 21 (32) | DD | 42.53 ± 5.86 | ||
| 43 (66) | ID + DD | 45.96 ± 4.20 | .587* | |
| Women | 7 (18) | II | 25.99 ± 5.64 | .141 |
| 26 (67) | ID | 43.53 ± 5.27 | ||
| 6 (21) | DD | 61.02 ± 1.69 | ||
| 32 (82) | ID + DD | 47.21 ± 4.53 | .141* |
*
II versus ID + DD.